Pet OTC Medication - Global and China Top Players Market Share and Ranking 2024
This report studies and analyses global Pet OTC Medication status and future trends, helps the client to determine the Pet OTC Medication market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pet OTC Medication, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pet OTC Medication market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Pet OTC Medication sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Pet OTC Medication sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Pet OTC Medication key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pet OTC Medication key producing regions, capacity, production, and year over year growth
(6) Pet OTC Medication industry chains, upstream, midstream and downstream
According to latest study, the global market for Pet OTC Medication should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Pet OTC Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Pet OTC Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Pet Specialty Stores grew percent to account for percent of the total market sales, and Veterinary Clinics grew percent.
Market segment by players, this report covers
Bayer AG
Boehringer Ingelheim International GmbH
Covetrus
Dechra Pharmaceuticals
Elanco Animal Health
Heska
IDEXX Laboratories
Kyoritsu Seiyaku
Merck & Co.
Phibro Animal Health
Sequent Scientific
Vetoquinol SA
Virbac SA
Zoetis
Market segment by Type, covers
Tablets
Capsules
Sprays
Market segment by Application, can be divided into
Pet Specialty Stores
Veterinary Clinics
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pet OTC Medication product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pet OTC Medication market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Pet OTC Medication market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Pet OTC Medication, percent & CAGR, 2018-2029
Chapter 5: Pet OTC Medication industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pet OTC Medication Definition
1.2 Global Pet OTC Medication Market Size and Forecast
1.2.1 By Consumption Value, Global Pet OTC Medication Market Size，2018-2029
1.2.2 By Sales Quantity, Global Pet OTC Medication Market Size，2018-2029
1.2.3 Global Pet OTC Medication Average Selling Price (ASP)，2018-2029
1.3 China Pet OTC Medication Market Size and Forecast
1.3.1 By Consumption Value, China Pet OTC Medication Market Size，2018-2029
1.3.2 By Sales Quantity, China Pet OTC Medication Market Size，2018-2029
1.3.3 China Pet OTC Medication Average Selling Price (ASP)， 2018-2029
1.4 Share of China Pet OTC Medication Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pet OTC Medication Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Pet OTC Medication Market Share in Global, 2018-2029
1.4.3 Pet OTC Medication Market Size: China VS Global, 2018-2029
1.5 Pet OTC Medication Market Dynamics
1.5.1 Pet OTC Medication Market Drivers
1.5.2 Pet OTC Medication Market Restraints
1.5.3 Pet OTC Medication Industry Trends
1.5.4 Pet OTC Medication Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pet OTC Medication, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Pet OTC Medication, Global Market Share by Company, 2018-2023
2.3 Pet OTC Medication Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Pet OTC Medication Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pet OTC Medication Concentration Ratio
2.6 Global Pet OTC Medication Mergers & Acquisitions, Expansion Plans
2.7 Global Pet OTC Medication Manufacturers Product Type
2.8 Head Office and Pet OTC Medication Production Site of Key Manufacturer
2.9 Pet OTC Medication Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pet OTC Medication, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Pet OTC Medication, China Market Share by Company, 2018-2023
3.3 China Pet OTC Medication Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pet OTC Medication Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Pet OTC Medication Capacity by Region
4.3 Global Pet OTC Medication Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Pet OTC Medication Production by Region, 2018-2029
4.5 Global Pet OTC Medication Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pet OTC Medication Industry Chain
5.2 Pet OTC Medication Upstream Analysis
5.2.1 Pet OTC Medication Core Raw Materials
5.2.2 Main Manufacturers of Pet OTC Medication Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pet OTC Medication Production Mode
5.6 Pet OTC Medication Procurement Model
5.7 Pet OTC Medication Industry Sales Model and Sales Channels
5.7.1 Pet OTC Medication Sales Model
5.7.2 Pet OTC Medication Typical Distributors
6 Sights by Type
6.1 Pet OTC Medication Classification
6.1.1 Tablets
6.1.2 Capsules
6.1.3 Sprays
6.2 By Type, Global Pet OTC Medication Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pet OTC Medication Consumption Value, 2018-2029
6.4 By Type, Global Pet OTC Medication Sales Quantity, 2018-2029
6.5 By Type, Global Pet OTC Medication Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Pet OTC Medication Segment by Application
7.1.1 Pet Specialty Stores
7.1.2 Veterinary Clinics
7.1.3 Others
7.2 By Application, Global Pet OTC Medication Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pet OTC Medication Consumption Value, 2018-2029
7.4 By Application, Global Pet OTC Medication Sales Quantity, 2018-2029
7.5 By Application, Global Pet OTC Medication Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pet OTC Medication Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Pet OTC Medication Consumption Value, 2018-2029
8.3 By Region, Global Pet OTC Medication Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Pet OTC Medication & Forecasts, 2018-2029
8.4.2 By Country, North America Pet OTC Medication Market Size Market Share
8.5 Europe
8.5.1 Europe Pet OTC Medication Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pet OTC Medication Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pet OTC Medication Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pet OTC Medication Market Size Market Share
8.7 South America
8.7.1 South America Pet OTC Medication Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pet OTC Medication Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pet OTC Medication Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Pet OTC Medication Consumption Value, 2018-2029
9.3 By Country, Global Pet OTC Medication Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Pet OTC Medication Market Size, 2018-2029
9.4.2 By Type, U.S. Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pet OTC Medication Market Size, 2018-2029
9.5.2 By Type, Europe Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Pet OTC Medication Market Size, 2018-2029
9.6.2 By Type, China Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pet OTC Medication Market Size, 2018-2029
9.7.2 By Type, Japan Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pet OTC Medication Market Size, 2018-2029
9.8.2 By Type, South Korea Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pet OTC Medication Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Pet OTC Medication Market Size, 2018-2029
9.10.2 By Type, India Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pet OTC Medication Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bayer AG
10.1.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.1.2 Bayer AG Pet OTC Medication Models, Specifications, and Application
10.1.3 Bayer AG Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bayer AG Company Profile and Main Business
10.1.5 Bayer AG Recent Developments
10.2 Boehringer Ingelheim International GmbH
10.2.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
10.2.2 Boehringer Ingelheim International GmbH Pet OTC Medication Models, Specifications, and Application
10.2.3 Boehringer Ingelheim International GmbH Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.2.5 Boehringer Ingelheim International GmbH Recent Developments
10.3 Covetrus
10.3.1 Covetrus Company Information, Head Office, Market Area, and Industry Position
10.3.2 Covetrus Pet OTC Medication Models, Specifications, and Application
10.3.3 Covetrus Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Covetrus Company Profile and Main Business
10.3.5 Covetrus Recent Developments
10.4 Dechra Pharmaceuticals
10.4.1 Dechra Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Dechra Pharmaceuticals Pet OTC Medication Models, Specifications, and Application
10.4.3 Dechra Pharmaceuticals Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Dechra Pharmaceuticals Company Profile and Main Business
10.4.5 Dechra Pharmaceuticals Recent Developments
10.5 Elanco Animal Health
10.5.1 Elanco Animal Health Company Information, Head Office, Market Area, and Industry Position
10.5.2 Elanco Animal Health Pet OTC Medication Models, Specifications, and Application
10.5.3 Elanco Animal Health Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Elanco Animal Health Company Profile and Main Business
10.5.5 Elanco Animal Health Recent Developments
10.6 Heska
10.6.1 Heska Company Information, Head Office, Market Area, and Industry Position
10.6.2 Heska Pet OTC Medication Models, Specifications, and Application
10.6.3 Heska Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Heska Company Profile and Main Business
10.6.5 Heska Recent Developments
10.7 IDEXX Laboratories
10.7.1 IDEXX Laboratories Company Information, Head Office, Market Area, and Industry Position
10.7.2 IDEXX Laboratories Pet OTC Medication Models, Specifications, and Application
10.7.3 IDEXX Laboratories Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 IDEXX Laboratories Company Profile and Main Business
10.7.5 IDEXX Laboratories Recent Developments
10.8 Kyoritsu Seiyaku
10.8.1 Kyoritsu Seiyaku Company Information, Head Office, Market Area, and Industry Position
10.8.2 Kyoritsu Seiyaku Pet OTC Medication Models, Specifications, and Application
10.8.3 Kyoritsu Seiyaku Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Kyoritsu Seiyaku Company Profile and Main Business
10.8.5 Kyoritsu Seiyaku Recent Developments
10.9 Merck & Co.
10.9.1 Merck & Co. Company Information, Head Office, Market Area, and Industry Position
10.9.2 Merck & Co. Pet OTC Medication Models, Specifications, and Application
10.9.3 Merck & Co. Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Merck & Co. Company Profile and Main Business
10.9.5 Merck & Co. Recent Developments
10.10 Phibro Animal Health
10.10.1 Phibro Animal Health Company Information, Head Office, Market Area, and Industry Position
10.10.2 Phibro Animal Health Pet OTC Medication Models, Specifications, and Application
10.10.3 Phibro Animal Health Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Phibro Animal Health Company Profile and Main Business
10.10.5 Phibro Animal Health Recent Developments
10.11 Sequent Scientific
10.11.1 Sequent Scientific Company Information, Head Office, Market Area, and Industry Position
10.11.2 Sequent Scientific Pet OTC Medication Models, Specifications, and Application
10.11.3 Sequent Scientific Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Sequent Scientific Company Profile and Main Business
10.11.5 Sequent Scientific Recent Developments
10.12 Vetoquinol SA
10.12.1 Vetoquinol SA Company Information, Head Office, Market Area, and Industry Position
10.12.2 Vetoquinol SA Pet OTC Medication Models, Specifications, and Application
10.12.3 Vetoquinol SA Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Vetoquinol SA Company Profile and Main Business
10.12.5 Vetoquinol SA Recent Developments
10.13 Virbac SA
10.13.1 Virbac SA Company Information, Head Office, Market Area, and Industry Position
10.13.2 Virbac SA Pet OTC Medication Models, Specifications, and Application
10.13.3 Virbac SA Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Virbac SA Company Profile and Main Business
10.13.5 Virbac SA Recent Developments
10.14 Zoetis
10.14.1 Zoetis Company Information, Head Office, Market Area, and Industry Position
10.14.2 Zoetis Pet OTC Medication Models, Specifications, and Application
10.14.3 Zoetis Pet OTC Medication Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Zoetis Company Profile and Main Business
10.14.5 Zoetis Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pet OTC Medication Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pet OTC Medication Market Restraints
Table 3. Pet OTC Medication Market Trends
Table 4. Pet OTC Medication Industry Policy
Table 5. Global Pet OTC Medication Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Pet OTC Medication Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Pet OTC Medication Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Pet OTC Medication Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Pet OTC Medication Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Pet OTC Medication Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pet OTC Medication Mergers & Acquisitions, Expansion Plans
Table 12. Global Pet OTC Medication Manufacturers Product Type
Table 13. Head Office and Pet OTC Medication Production Site of Key Manufacturer
Table 14. Pet OTC Medication Capacity of Major Manufacturers and Future Plan
Table 15. China Pet OTC Medication Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Pet OTC Medication Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Pet OTC Medication Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Pet OTC Medication Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Pet OTC Medication Production by Region, 2018-2023, (K Units)
Table 20. Global Pet OTC Medication Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Pet OTC Medication Upstream (Raw Materials)
Table 22. Global Pet OTC Medication Typical Customers
Table 23. Pet OTC Medication Typical Distributors
Table 24. By Type, Global Pet OTC Medication Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Pet OTC Medication Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Pet OTC Medication Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Pet OTC Medication Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Pet OTC Medication Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Pet OTC Medication Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Pet OTC Medication Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Pet OTC Medication Sales Quantity Market Share, 2018-2029
Table 34. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 35. Bayer AG Pet OTC Medication Models, Specifications, and Application
Table 36. Bayer AG Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bayer AG Company Profile and Main Business
Table 38. Bayer AG Recent Developments
Table 39. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
Table 40. Boehringer Ingelheim International GmbH Pet OTC Medication Models, Specifications, and Application
Table 41. Boehringer Ingelheim International GmbH Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 43. Boehringer Ingelheim International GmbH Recent Developments
Table 44. Covetrus Company Information, Head Office, Market Area, and Industry Position
Table 45. Covetrus Pet OTC Medication Models, Specifications, and Application
Table 46. Covetrus Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Covetrus Company Profile and Main Business
Table 48. Covetrus Recent Developments
Table 49. Dechra Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 50. Dechra Pharmaceuticals Pet OTC Medication Models, Specifications, and Application
Table 51. Dechra Pharmaceuticals Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Dechra Pharmaceuticals Company Profile and Main Business
Table 53. Dechra Pharmaceuticals Recent Developments
Table 54. Elanco Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 55. Elanco Animal Health Pet OTC Medication Models, Specifications, and Application
Table 56. Elanco Animal Health Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Elanco Animal Health Company Profile and Main Business
Table 58. Elanco Animal Health Recent Developments
Table 59. Heska Company Information, Head Office, Market Area, and Industry Position
Table 60. Heska Pet OTC Medication Models, Specifications, and Application
Table 61. Heska Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Heska Company Profile and Main Business
Table 63. Heska Recent Developments
Table 64. IDEXX Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 65. IDEXX Laboratories Pet OTC Medication Models, Specifications, and Application
Table 66. IDEXX Laboratories Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. IDEXX Laboratories Company Profile and Main Business
Table 68. IDEXX Laboratories Recent Developments
Table 69. Kyoritsu Seiyaku Company Information, Head Office, Market Area, and Industry Position
Table 70. Kyoritsu Seiyaku Pet OTC Medication Models, Specifications, and Application
Table 71. Kyoritsu Seiyaku Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Kyoritsu Seiyaku Company Profile and Main Business
Table 73. Kyoritsu Seiyaku Recent Developments
Table 74. Merck & Co. Company Information, Head Office, Market Area, and Industry Position
Table 75. Merck & Co. Pet OTC Medication Models, Specifications, and Application
Table 76. Merck & Co. Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Merck & Co. Company Profile and Main Business
Table 78. Merck & Co. Recent Developments
Table 79. Phibro Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 80. Phibro Animal Health Pet OTC Medication Models, Specifications, and Application
Table 81. Phibro Animal Health Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Phibro Animal Health Company Profile and Main Business
Table 83. Phibro Animal Health Recent Developments
Table 84. Sequent Scientific Company Information, Head Office, Market Area, and Industry Position
Table 85. Sequent Scientific Pet OTC Medication Models, Specifications, and Application
Table 86. Sequent Scientific Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Sequent Scientific Company Profile and Main Business
Table 88. Sequent Scientific Recent Developments
Table 89. Vetoquinol SA Company Information, Head Office, Market Area, and Industry Position
Table 90. Vetoquinol SA Pet OTC Medication Models, Specifications, and Application
Table 91. Vetoquinol SA Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Vetoquinol SA Company Profile and Main Business
Table 93. Vetoquinol SA Recent Developments
Table 94. Virbac SA Company Information, Head Office, Market Area, and Industry Position
Table 95. Virbac SA Pet OTC Medication Models, Specifications, and Application
Table 96. Virbac SA Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Virbac SA Company Profile and Main Business
Table 98. Virbac SA Recent Developments
Table 99. Zoetis Company Information, Head Office, Market Area, and Industry Position
Table 100. Zoetis Pet OTC Medication Models, Specifications, and Application
Table 101. Zoetis Pet OTC Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Zoetis Company Profile and Main Business
Table 103. Zoetis Recent Developments
List of Figures
Figure 1. Pet OTC Medication Picture
Figure 2. Global Pet OTC Medication Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Pet OTC Medication Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Pet OTC Medication Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Pet OTC Medication Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Pet OTC Medication Sales Quantity (K Units) & (2018-2029)
Figure 7. China Pet OTC Medication Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Pet OTC Medication Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Pet OTC Medication Market Share of Global, 2018-2029
Figure 10. Global Pet OTC Medication Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Pet OTC Medication Key Participants, Market Share, 2022
Figure 12. Global Pet OTC Medication Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Pet OTC Medication Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Pet OTC Medication Production Market Share & Forecast by Region, 2018-2029
Figure 15. Pet OTC Medication Industry Chain
Figure 16. Pet OTC Medication Procurement Model
Figure 17. Pet OTC Medication Sales Model
Figure 18. Pet OTC Medication Sales Channels, Direct Sales, and Distribution
Figure 19. Tablets
Figure 20. Capsules
Figure 21. Sprays
Figure 22. By Type, Global Pet OTC Medication Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Pet OTC Medication Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Pet OTC Medication Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Pet OTC Medication Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Pet Specialty Stores
Figure 28. Veterinary Clinics
Figure 29. Others
Figure 30. By Application, Global Pet OTC Medication Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Pet OTC Medication Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Pet OTC Medication Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Pet OTC Medication Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Pet OTC Medication Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Pet OTC Medication Sales Quantity Market Share, 2018-2029
Figure 37. North America Pet OTC Medication Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Pet OTC Medication Consumption Value Market Share, 2022
Figure 39. Europe Pet OTC Medication Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Pet OTC Medication Consumption Value Market Share, 2022
Figure 41. Asia Pacific Pet OTC Medication Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Pet OTC Medication Consumption Value Market Share, 2022
Figure 43. South America Pet OTC Medication Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Pet OTC Medication Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Pet OTC Medication Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Pet OTC Medication Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Pet OTC Medication Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|